BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12771131)

  • 1. Repressors of androgen and progesterone receptor action.
    Agoulnik IU; Krause WC; Bingman WE; Rahman HT; Amrikachi M; Ayala GE; Weigel NL
    J Biol Chem; 2003 Aug; 278(33):31136-48. PubMed ID: 12771131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
    Berrevoets CA; Umar A; Trapman J; Brinkmann AO
    Biochem J; 2004 May; 379(Pt 3):731-8. PubMed ID: 14744261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists.
    Hodgson MC; Astapova I; Cheng S; Lee LJ; Verhoeven MC; Choi E; Balk SP; Hollenberg AN
    J Biol Chem; 2005 Feb; 280(8):6511-9. PubMed ID: 15598662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.
    Wagner BL; Norris JD; Knotts TA; Weigel NL; McDonnell DP
    Mol Cell Biol; 1998 Mar; 18(3):1369-78. PubMed ID: 9488452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1.
    Holter E; Kotaja N; Mäkela S; Strauss L; Kietz S; Jänne OA; Gustafsson JA; Palvimo JJ; Treuter E
    Mol Endocrinol; 2002 Mar; 16(3):515-28. PubMed ID: 11875111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1.
    Crawford PA; Dorn C; Sadovsky Y; Milbrandt J
    Mol Cell Biol; 1998 May; 18(5):2949-56. PubMed ID: 9566914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.
    Hodgson MC; Shen HC; Hollenberg AN; Balk SP
    Mol Cancer Ther; 2008 Oct; 7(10):3187-94. PubMed ID: 18852122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
    Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
    Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC; Astapova I; Hollenberg AN; Balk SP
    Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.
    Song KH; Park YY; Park KC; Hong CY; Park JH; Shong M; Lee K; Choi HS
    Mol Endocrinol; 2004 Aug; 18(8):1929-40. PubMed ID: 15155786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of two distinct functional isoforms of dosage-sensitive sex reversal-adrenal hypoplasia congenita-critical region on the X chromosome gene 1 (DAX-1) by alternative splicing.
    Hossain A; Li C; Saunders GF
    Mol Endocrinol; 2004 Jun; 18(6):1428-37. PubMed ID: 15044589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role of the loop region between helices H6 and H7 within the orphan nuclear receptors small heterodimer partner and DAX-1.
    Park YY; Kim HJ; Kim JY; Kim MY; Song KH; Cheol Park K; Yu KY; Shong M; Kim KH; Choi HS
    Mol Endocrinol; 2004 May; 18(5):1082-95. PubMed ID: 14963109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the LXXLL-motif and activation function 2 domain in subcellular localization of Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1).
    Kawajiri K; Ikuta T; Suzuki T; Kusaka M; Muramatsu M; Fujieda K; Tachibana M; Morohashi K
    Mol Endocrinol; 2003 Jun; 17(6):994-1004. PubMed ID: 12610109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Androgen receptor and SMRT].
    Liao GQ; Tang HH; Lü XS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):157-62. PubMed ID: 16145900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexually dimorphic expression of Dax-1 in the adrenal cortex.
    Mukai T; Kusaka M; Kawabe K; Goto K; Nawata H; Fujieda K; Morohashi K
    Genes Cells; 2002 Jul; 7(7):717-29. PubMed ID: 12081648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients.
    Lehmann SG; Wurtz JM; Renaud JP; Sassone-Corsi P; Lalli E
    Hum Mol Genet; 2003 May; 12(9):1063-72. PubMed ID: 12700175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status.
    Conde I; Alfaro JM; Fraile B; Ruíz A; Paniagua R; Arenas MI
    Breast Cancer Res; 2004; 6(3):R140-8. PubMed ID: 15084237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.